APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nursing Products Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nursing Products Testing Market Outlook and Growth Opportunities 2026

Report ID 174199450416 April 2026Not stated

Choose your research edition.

Industry ResearchNursing Products Testing Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Nursing Products Testing Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Nursing Products Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nursing Products Testing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Nursing Products Testing Market Analysis and Forecast 2026-2032249 pages · $4,950 USD

Market perspective

The global Nursing Products Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nursing Products Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nursing Products Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nursing Products Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nursing Products Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nursing Products Testing market include Intertek, SGS, Eurofins, CIRS GROUP, UL, Bureau Veritas, TUV SUD, Dekra and ALS Global, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Nursing Products Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nursing Products Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nursing Products Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Nursing Products Testing market.

Nursing Products Testing Segment by Company

Intertek

SGS

Eurofins

CIRS GROUP

UL

Bureau Veritas

TUV SUD

Dekra

ALS Global

Centre Testing International

Korea Testing & Research Institute

KOTITI

HQTS

Global Inspection Managing

TÜV Rheinland

CAS Testing Technical Services

Spectro Analytical Labs

CMA Testing

Jasan Cosmetic Laboratories

Cosmetic Testing Lab

Microchem Laboratory

CE.Way Regulatory Consultants

QACS - The Challenge Test Laboratory

Contract Laboratory

AEMTEK Laboratories

Hangzhou C&K Testing Technic Co ., Ltd

Kirei-Testing-Labo

Nursing Products Testing Segment by Type

Microbiology Testing

Challenge Test

Safety Assessment

Nursing Products Testing Segment by Application

Enterprise

Individual

Nursing Products Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nursing Products Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Nursing Products Testing key companies, revenue, market share, and recent developments.

3. To split the Nursing Products Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Nursing Products Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nursing Products Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Nursing Products Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nursing Products Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nursing Products Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nursing Products Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nursing Products Testing industry.

Chapter 3: Detailed analysis of Nursing Products Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Nursing Products Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Nursing Products Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nursing Products Testing Industry Trends Table 2. Nursing Products Testing Industry Drivers Table 3. Nursing Products Testing Industry Opportunities and Challenges Table 4. Nursing Products Testing Industry Restraints Table 5. Global Nursing Products Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nursing Products Testing Revenue Share by Company (2021-2026) Table 7. Global Nursing Products Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Nursing Products Testing Key Company Manufacturing Base & Headquarters Table 9. Global Nursing Products Testing Company, Product Type & Application Table 10. Global Nursing Products Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Nursing Products Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Microbiology Testing Table 15. Significant Companies of Challenge Test Table 16. Significant Companies of Safety Assessment Table 17. Global Nursing Products Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Nursing Products Testing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Nursing Products Testing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Nursing Products Testing Sales Value Share by Type (2021-2026) Table 21. Global Nursing Products Testing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Enterprise Table 23. Significant Companies of Individual Table 24. Global Nursing Products Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nursing Products Testing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Nursing Products Testing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Nursing Products Testing Sales Value Share by Application (2021-2026) Table 28. Global Nursing Products Testing Sales Value Share by Application (2027-2032) Table 29. Global Nursing Products Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Nursing Products Testing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Nursing Products Testing Sales Value Share by Region (2021-2026) Table 32. Global Nursing Products Testing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Nursing Products Testing Sales Value Share by Region (2027-2032) Table 34. Global Nursing Products Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Nursing Products Testing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Nursing Products Testing Sales Value Market Share by Country (2021-2026) Table 37. Global Nursing Products Testing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Nursing Products Testing Sales Value Market Share by Country (2027-2032) Table 39. Intertek Company Information Table 40. Intertek Business Overview Table 41. Intertek Nursing Products Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Intertek Nursing Products Testing Product Portfolio Table 43. Intertek Recent Development Table 44. SGS Company Information Table 45. SGS Business Overview Table 46. SGS Nursing Products Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. SGS Nursing Products Testing Product Portfolio Table 48. SGS Recent Development Table 49. Eurofins Company Information Table 50. Eurofins Business Overview Table 51. Eurofins Nursing Products Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Eurofins Nursing Products Testing Product Portfolio Table 53. Eurofins Recent Development Table 54. CIRS GROUP Company Information Table 55. CIRS GROUP Business Overview Table 56. CIRS GROUP Nursing Products Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. CIRS GROUP Nursing Products Testing Product Portfolio Table 58. CIRS GROUP Recent Development Table 59. UL Company Information Table 60. UL Business Overview Table 61. UL Nursing Products Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. UL Nursing Products Testing Product Portfolio Table 63. UL Recent Development Table 64. Bureau Veritas Company Information Table 65. Bureau Veritas Business Overview Table 66. Bureau Veritas Nursing Products Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Bureau Veritas Nursing Products Testing Product Portfolio Table 68. Bureau Veritas Recent Development Table 69. TUV SUD Company Information Table 70. TUV SUD Business Overview Table 71. TUV SUD Nursing Products Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. TUV SUD Nursing Products Testing Product Portfolio Table 73. TUV SUD Recent Development Table 74. Dekra Company Information Table 75. Dekra Business Overview Table 76. Dekra Nursing Products Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Dekra Nursing Products Testing Product Portfolio Table 78. Dekra Recent Development Table 79. ALS Global Company Information Table 80. ALS Global Business Overview Table 81. ALS Global Nursing Products Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. ALS Global Nursing Products Testing Product Portfolio Table 83. ALS Global Recent Development Table 84. Centre Testing International Company Information Table 85. Centre Testing International Business Overview Table 86. Centre Testing International Nursing Products Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Centre Testing International Nursing Products Testing Product Portfolio Table 88. Centre Testing International Recent Development Table 89. Korea Testing & Research Institute Company Information Table 90. Korea Testing & Research Institute Business Overview Table 91. Korea Testing & Research Institute Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Korea Testing & Research Institute Nursing Products Testing Product Portfolio Table 93. Korea Testing & Research Institute Recent Development Table 94. KOTITI Company Information Table 95. KOTITI Business Overview Table 96. KOTITI Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. KOTITI Nursing Products Testing Product Portfolio Table 98. KOTITI Recent Development Table 99. HQTS Company Information Table 100. HQTS Business Overview Table 101. HQTS Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. HQTS Nursing Products Testing Product Portfolio Table 103. HQTS Recent Development Table 104. Global Inspection Managing Company Information Table 105. Global Inspection Managing Business Overview Table 106. Global Inspection Managing Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Global Inspection Managing Nursing Products Testing Product Portfolio Table 108. Global Inspection Managing Recent Development Table 109. TÜV Rheinland Company Information Table 110. TÜV Rheinland Business Overview Table 111. TÜV Rheinland Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. TÜV Rheinland Nursing Products Testing Product Portfolio Table 113. TÜV Rheinland Recent Development Table 114. CAS Testing Technical Services Company Information Table 115. CAS Testing Technical Services Business Overview Table 116. CAS Testing Technical Services Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. CAS Testing Technical Services Nursing Products Testing Product Portfolio Table 118. CAS Testing Technical Services Recent Development Table 119. Spectro Analytical Labs Company Information Table 120. Spectro Analytical Labs Business Overview Table 121. Spectro Analytical Labs Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Spectro Analytical Labs Nursing Products Testing Product Portfolio Table 123. Spectro Analytical Labs Recent Development Table 124. CMA Testing Company Information Table 125. CMA Testing Business Overview Table 126. CMA Testing Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. CMA Testing Nursing Products Testing Product Portfolio Table 128. CMA Testing Recent Development Table 129. Jasan Cosmetic Laboratories Company Information Table 130. Jasan Cosmetic Laboratories Business Overview Table 131. Jasan Cosmetic Laboratories Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Jasan Cosmetic Laboratories Nursing Products Testing Product Portfolio Table 133. Jasan Cosmetic Laboratories Recent Development Table 134. Cosmetic Testing Lab Company Information Table 135. Cosmetic Testing Lab Business Overview Table 136. Cosmetic Testing Lab Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Cosmetic Testing Lab Nursing Products Testing Product Portfolio Table 138. Cosmetic Testing Lab Recent Development Table 139. Microchem Laboratory Company Information Table 140. Microchem Laboratory Business Overview Table 141. Microchem Laboratory Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Microchem Laboratory Nursing Products Testing Product Portfolio Table 143. Microchem Laboratory Recent Development Table 144. CE.Way Regulatory Consultants Company Information Table 145. CE.Way Regulatory Consultants Business Overview Table 146. CE.Way Regulatory Consultants Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. CE.Way Regulatory Consultants Nursing Products Testing Product Portfolio Table 148. CE.Way Regulatory Consultants Recent Development Table 149. QACS - The Challenge Test Laboratory Company Information Table 150. QACS - The Challenge Test Laboratory Business Overview Table 151. QACS - The Challenge Test Laboratory Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. QACS - The Challenge Test Laboratory Nursing Products Testing Product Portfolio Table 153. QACS - The Challenge Test Laboratory Recent Development Table 154. Contract Laboratory Company Information Table 155. Contract Laboratory Business Overview Table 156. Contract Laboratory Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. Contract Laboratory Nursing Products Testing Product Portfolio Table 158. Contract Laboratory Recent Development Table 159. AEMTEK Laboratories Company Information Table 160. AEMTEK Laboratories Business Overview Table 161. AEMTEK Laboratories Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. AEMTEK Laboratories Nursing Products Testing Product Portfolio Table 163. AEMTEK Laboratories Recent Development Table 164. Hangzhou C&K Testing Technic Co ., Ltd Company Information Table 165. Hangzhou C&K Testing Technic Co ., Ltd Business Overview Table 166. Hangzhou C&K Testing Technic Co ., Ltd Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. Hangzhou C&K Testing Technic Co ., Ltd Nursing Products Testing Product Portfolio Table 168. Hangzhou C&K Testing Technic Co ., Ltd Recent Development Table 169. Kirei-Testing-Labo Company Information Table 170. Kirei-Testing-Labo Business Overview Table 171. Kirei-Testing-Labo Nursing Products Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 172. Kirei-Testing-Labo Nursing Products Testing Product Portfolio Table 173. Kirei-Testing-Labo Recent Development Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Nursing Products Testing Product Image Figure 2. Global Nursing Products Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nursing Products Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Nursing Products Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Microbiology Testing Image Figure 8. Challenge Test Image Figure 9. Safety Assessment Image Figure 10. Global Nursing Products Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Nursing Products Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Nursing Products Testing Sales Value Share by Type (2021-2032) Figure 13. Enterprise Image Figure 14. Individual Image Figure 15. Global Nursing Products Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Nursing Products Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Nursing Products Testing Sales Value Share by Application (2021-2032) Figure 18. Global Nursing Products Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Nursing Products Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Nursing Products Testing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Nursing Products Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Nursing Products Testing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Nursing Products Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Nursing Products Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Nursing Products Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Nursing Products Testing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Nursing Products Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Nursing Products Testing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Nursing Products Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Nursing Products Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Nursing Products Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Nursing Products Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Microbiology Testing
  • Challenge Test
  • Safety Assessment
Applications
  • Enterprise
  • Individual
Companies covered
  • Intertek
  • SGS
  • Eurofins
  • CIRS GROUP
  • UL
  • Bureau Veritas
  • TUV SUD
  • Dekra
  • ALS Global
  • Centre Testing International
  • Korea Testing & Research Institute
  • KOTITI
  • HQTS
  • Global Inspection Managing
  • TÜV Rheinland
  • CAS Testing Technical Services
  • Spectro Analytical Labs
  • CMA Testing
  • Jasan Cosmetic Laboratories
  • Cosmetic Testing Lab
  • Microchem Laboratory
  • CE.Way Regulatory Consultants
  • QACS - The Challenge Test Laboratory
  • Contract Laboratory
  • AEMTEK Laboratories
  • Hangzhou C&K Testing Technic Co ., Ltd
  • Kirei-Testing-Labo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nursing Products Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nursing Products Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Nursing Products Testing Market Dynamics
  1. 2.1 Nursing Products Testing Industry Trends
  2. 2.2 Nursing Products Testing Industry Drivers
  3. 2.3 Nursing Products Testing Industry Opportunities and Challenges
  4. 2.4 Nursing Products Testing Industry Restraints
3 Nursing Products Testing Market by Company
  1. 3.1 Global Nursing Products Testing Company Revenue Ranking in 2025
  2. 3.2 Global Nursing Products Testing Revenue by Company (2021-2026)
  3. 3.3 Global Nursing Products Testing Company Ranking (2024-2026)
  4. 3.4 Global Nursing Products Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Nursing Products Testing Company Product Type and Application
  6. 3.6 Global Nursing Products Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Nursing Products Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Nursing Products Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Nursing Products Testing Market by Type
  1. 4.1 Nursing Products Testing Type Introduction
  2. 4.1.1 Microbiology Testing
  3. 4.1.2 Challenge Test
  4. 4.1.3 Safety Assessment
  5. 4.2 Global Nursing Products Testing Sales Value by Type
  6. 4.2.1 Global Nursing Products Testing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nursing Products Testing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Nursing Products Testing Sales Value Share by Type (2021-2032)
5 Nursing Products Testing Market by Application
  1. 5.1 Nursing Products Testing Application Introduction
  2. 5.1.1 Enterprise
  3. 5.1.2 Individual
  4. 5.2 Global Nursing Products Testing Sales Value by Application
  5. 5.2.1 Global Nursing Products Testing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Nursing Products Testing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Nursing Products Testing Sales Value Share by Application (2021-2032)
6 Nursing Products Testing Regional Value Analysis
  1. 6.1 Global Nursing Products Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nursing Products Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Nursing Products Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Nursing Products Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nursing Products Testing Sales Value (2021-2032)
  7. 6.3.2 North America Nursing Products Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Nursing Products Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Nursing Products Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Nursing Products Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Nursing Products Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Nursing Products Testing Sales Value (2021-2032)
  16. 6.6.2 South America Nursing Products Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Nursing Products Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Nursing Products Testing Sales Value Share by Country, 2025 VS 2032
7 Nursing Products Testing Country-level Value Analysis
  1. 7.1 Global Nursing Products Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nursing Products Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Nursing Products Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Nursing Products Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Nursing Products Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Nursing Products Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Nursing Products Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Nursing Products Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Nursing Products Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Nursing Products Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Nursing Products Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Nursing Products Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Nursing Products Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Nursing Products Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Nursing Products Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Nursing Products Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Nursing Products Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Nursing Products Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Nursing Products Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Nursing Products Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Nursing Products Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Nursing Products Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Nursing Products Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Nursing Products Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Nursing Products Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Nursing Products Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Nursing Products Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Nursing Products Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Nursing Products Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Nursing Products Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Nursing Products Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Nursing Products Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Nursing Products Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Nursing Products Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Intertek
  2. 8.1.1 Intertek Company Information
  3. 8.1.2 Intertek Business Overview
  4. 8.1.3 Intertek Nursing Products Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Intertek Nursing Products Testing Product Portfolio
  6. 8.1.5 Intertek Recent Developments
  7. 8.2 SGS
  8. 8.2.1 SGS Company Information
  9. 8.2.2 SGS Business Overview
  10. 8.2.3 SGS Nursing Products Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SGS Nursing Products Testing Product Portfolio
  12. 8.2.5 SGS Recent Developments
  13. 8.3 Eurofins
  14. 8.3.1 Eurofins Company Information
  15. 8.3.2 Eurofins Business Overview
  16. 8.3.3 Eurofins Nursing Products Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eurofins Nursing Products Testing Product Portfolio
  18. 8.3.5 Eurofins Recent Developments
  19. 8.4 CIRS GROUP
  20. 8.4.1 CIRS GROUP Company Information
  21. 8.4.2 CIRS GROUP Business Overview
  22. 8.4.3 CIRS GROUP Nursing Products Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CIRS GROUP Nursing Products Testing Product Portfolio
  24. 8.4.5 CIRS GROUP Recent Developments
  25. 8.5 UL
  26. 8.5.1 UL Company Information
  27. 8.5.2 UL Business Overview
  28. 8.5.3 UL Nursing Products Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 UL Nursing Products Testing Product Portfolio
  30. 8.5.5 UL Recent Developments
  31. 8.6 Bureau Veritas
  32. 8.6.1 Bureau Veritas Company Information
  33. 8.6.2 Bureau Veritas Business Overview
  34. 8.6.3 Bureau Veritas Nursing Products Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bureau Veritas Nursing Products Testing Product Portfolio
  36. 8.6.5 Bureau Veritas Recent Developments
  37. 8.7 TUV SUD
  38. 8.7.1 TUV SUD Company Information
  39. 8.7.2 TUV SUD Business Overview
  40. 8.7.3 TUV SUD Nursing Products Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 TUV SUD Nursing Products Testing Product Portfolio
  42. 8.7.5 TUV SUD Recent Developments
  43. 8.8 Dekra
  44. 8.8.1 Dekra Company Information
  45. 8.8.2 Dekra Business Overview
  46. 8.8.3 Dekra Nursing Products Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Dekra Nursing Products Testing Product Portfolio
  48. 8.8.5 Dekra Recent Developments
  49. 8.9 ALS Global
  50. 8.9.1 ALS Global Company Information
  51. 8.9.2 ALS Global Business Overview
  52. 8.9.3 ALS Global Nursing Products Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ALS Global Nursing Products Testing Product Portfolio
  54. 8.9.5 ALS Global Recent Developments
  55. 8.10 Centre Testing International
  56. 8.10.1 Centre Testing International Company Information
  57. 8.10.2 Centre Testing International Business Overview
  58. 8.10.3 Centre Testing International Nursing Products Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Centre Testing International Nursing Products Testing Product Portfolio
  60. 8.10.5 Centre Testing International Recent Developments
  61. 8.11 Korea Testing & Research Institute
  62. 8.11.1 Korea Testing & Research Institute Company Information
  63. 8.11.2 Korea Testing & Research Institute Business Overview
  64. 8.11.3 Korea Testing & Research Institute Nursing Products Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Korea Testing & Research Institute Nursing Products Testing Product Portfolio
  66. 8.11.5 Korea Testing & Research Institute Recent Developments
  67. 8.12 KOTITI
  68. 8.12.1 KOTITI Company Information
  69. 8.12.2 KOTITI Business Overview
  70. 8.12.3 KOTITI Nursing Products Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 KOTITI Nursing Products Testing Product Portfolio
  72. 8.12.5 KOTITI Recent Developments
  73. 8.13 HQTS
  74. 8.13.1 HQTS Company Information
  75. 8.13.2 HQTS Business Overview
  76. 8.13.3 HQTS Nursing Products Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 HQTS Nursing Products Testing Product Portfolio
  78. 8.13.5 HQTS Recent Developments
  79. 8.14 Global Inspection Managing
  80. 8.14.1 Global Inspection Managing Company Information
  81. 8.14.2 Global Inspection Managing Business Overview
  82. 8.14.3 Global Inspection Managing Nursing Products Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Global Inspection Managing Nursing Products Testing Product Portfolio
  84. 8.14.5 Global Inspection Managing Recent Developments
  85. 8.15 TÜV Rheinland
  86. 8.15.1 TÜV Rheinland Company Information
  87. 8.15.2 TÜV Rheinland Business Overview
  88. 8.15.3 TÜV Rheinland Nursing Products Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 TÜV Rheinland Nursing Products Testing Product Portfolio
  90. 8.15.5 TÜV Rheinland Recent Developments
  91. 8.16 CAS Testing Technical Services
  92. 8.16.1 CAS Testing Technical Services Company Information
  93. 8.16.2 CAS Testing Technical Services Business Overview
  94. 8.16.3 CAS Testing Technical Services Nursing Products Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CAS Testing Technical Services Nursing Products Testing Product Portfolio
  96. 8.16.5 CAS Testing Technical Services Recent Developments
  97. 8.17 Spectro Analytical Labs
  98. 8.17.1 Spectro Analytical Labs Company Information
  99. 8.17.2 Spectro Analytical Labs Business Overview
  100. 8.17.3 Spectro Analytical Labs Nursing Products Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Spectro Analytical Labs Nursing Products Testing Product Portfolio
  102. 8.17.5 Spectro Analytical Labs Recent Developments
  103. 8.18 CMA Testing
  104. 8.18.1 CMA Testing Company Information
  105. 8.18.2 CMA Testing Business Overview
  106. 8.18.3 CMA Testing Nursing Products Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 CMA Testing Nursing Products Testing Product Portfolio
  108. 8.18.5 CMA Testing Recent Developments
  109. 8.19 Jasan Cosmetic Laboratories
  110. 8.19.1 Jasan Cosmetic Laboratories Company Information
  111. 8.19.2 Jasan Cosmetic Laboratories Business Overview
  112. 8.19.3 Jasan Cosmetic Laboratories Nursing Products Testing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Jasan Cosmetic Laboratories Nursing Products Testing Product Portfolio
  114. 8.19.5 Jasan Cosmetic Laboratories Recent Developments
  115. 8.20 Cosmetic Testing Lab
  116. 8.20.1 Cosmetic Testing Lab Company Information
  117. 8.20.2 Cosmetic Testing Lab Business Overview
  118. 8.20.3 Cosmetic Testing Lab Nursing Products Testing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Cosmetic Testing Lab Nursing Products Testing Product Portfolio
  120. 8.20.5 Cosmetic Testing Lab Recent Developments
  121. 8.21 Microchem Laboratory
  122. 8.21.1 Microchem Laboratory Company Information
  123. 8.21.2 Microchem Laboratory Business Overview
  124. 8.21.3 Microchem Laboratory Nursing Products Testing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Microchem Laboratory Nursing Products Testing Product Portfolio
  126. 8.21.5 Microchem Laboratory Recent Developments
  127. 8.22 CE.Way Regulatory Consultants
  128. 8.22.1 CE.Way Regulatory Consultants Company Information
  129. 8.22.2 CE.Way Regulatory Consultants Business Overview
  130. 8.22.3 CE.Way Regulatory Consultants Nursing Products Testing Revenue and Gross Margin (2021-2026)
  131. 8.22.4 CE.Way Regulatory Consultants Nursing Products Testing Product Portfolio
  132. 8.22.5 CE.Way Regulatory Consultants Recent Developments
  133. 8.23 QACS - The Challenge Test Laboratory
  134. 8.23.1 QACS - The Challenge Test Laboratory Company Information
  135. 8.23.2 QACS - The Challenge Test Laboratory Business Overview
  136. 8.23.3 QACS - The Challenge Test Laboratory Nursing Products Testing Revenue and Gross Margin (2021-2026)
  137. 8.23.4 QACS - The Challenge Test Laboratory Nursing Products Testing Product Portfolio
  138. 8.23.5 QACS - The Challenge Test Laboratory Recent Developments
  139. 8.24 Contract Laboratory
  140. 8.24.1 Contract Laboratory Company Information
  141. 8.24.2 Contract Laboratory Business Overview
  142. 8.24.3 Contract Laboratory Nursing Products Testing Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Contract Laboratory Nursing Products Testing Product Portfolio
  144. 8.24.5 Contract Laboratory Recent Developments
  145. 8.25 AEMTEK Laboratories
  146. 8.25.1 AEMTEK Laboratories Company Information
  147. 8.25.2 AEMTEK Laboratories Business Overview
  148. 8.25.3 AEMTEK Laboratories Nursing Products Testing Revenue and Gross Margin (2021-2026)
  149. 8.25.4 AEMTEK Laboratories Nursing Products Testing Product Portfolio
  150. 8.25.5 AEMTEK Laboratories Recent Developments
  151. 8.26 Hangzhou C&K Testing Technic Co ., Ltd
  152. 8.26.1 Hangzhou C&K Testing Technic Co ., Ltd Company Information
  153. 8.26.2 Hangzhou C&K Testing Technic Co ., Ltd Business Overview
  154. 8.26.3 Hangzhou C&K Testing Technic Co ., Ltd Nursing Products Testing Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Hangzhou C&K Testing Technic Co ., Ltd Nursing Products Testing Product Portfolio
  156. 8.26.5 Hangzhou C&K Testing Technic Co ., Ltd Recent Developments
  157. 8.27 Kirei-Testing-Labo
  158. 8.27.1 Kirei-Testing-Labo Company Information
  159. 8.27.2 Kirei-Testing-Labo Business Overview
  160. 8.27.3 Kirei-Testing-Labo Nursing Products Testing Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Kirei-Testing-Labo Nursing Products Testing Product Portfolio
  162. 8.27.5 Kirei-Testing-Labo Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst